Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 19, 2026 | CMS / Medicare | Botulinum Toxin Injections | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Intraarticular Knee Injections of Hyaluronan | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Computed Tomographic (CT) Colonography for Diagnostic Uses | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Nerve Conduction Studies and Electromyography | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Total Hip Arthroplasty | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: DecisionDx-UM (Uveal Melanoma) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Intraoperative Radiation Therapy | Metadata changed |
| May 19, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Transcranial Magnetic Stimulation (TMS) (DL34641) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Investigational Device Exemptions (IDE) - IDE Documentation Requirements for Studies with an FDA Approval dated January 01, 2015, or later | Metadata changed |
| May 19, 2026 | CMS / Medicare | Botulinum Toxin Injections | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Bevacizumab and biosimilars | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (DL38839) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next Generation Sequencing Testing in Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (DL39040) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers | Metadata changed |
| May 19, 2026 | CMS / Medicare | Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Tremor | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Spinal Cord Stimulators for Chronic Pain | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemaker | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Nerve Conduction Studies and Electromyography | Metadata changed |
| May 19, 2026 | CMS / Medicare | Measurement of Salivary Hormones | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Treatment of Varicose Veins of the Lower Extremities | Metadata changed |
| May 19, 2026 | CMS / Medicare | Proton Beam Therapy | Metadata changed |
| May 19, 2026 | CMS / Medicare | Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Peripheral Nerve Blocks | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Cervical Fusion | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Chemodenervation | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Hemophilia Factor Products | Metadata changed |
| May 19, 2026 | CMS / Medicare | Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities | Metadata changed |
| May 19, 2026 | CMS / Medicare | Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) | Metadata changed |